Recent Growth Due to Increase in Commercial Contracts
Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced it has plans to hire an additional 40 more team members as part of its growth expansion strategy in 2017.
The open positions at Rho range from entry-level research associate or administrative assistant positions to seasoned professionals, including clinical research associates (CRAs) and senior. project managers. The Chapel Hill-based CRO is also looking to fill more senior positions such as research scientists and a vice president of operations.
“With a strong, 33-year history of successful employee retention, we are fortunate to be in a position to add talented clinical research professionals to our already committed and richly experienced team of professionals,” said Russ Helms, Ph.D., chief executive officer for Rho. “Much of the growth is coming from our commercial business, but there are open positions throughout the company. We hope to have these positions filled over the next several months.”
Rho’s newest RTP additions include:
Over the last year, Rho has received several accolades recognizing its exemplary workplace practices and its achievements in creating a positive work environment that attracts and retains employees through a combination of benefits, working conditions and company culture. These recognitions include the Triangle Business Journal’s Corporate Philanthropy Award, Nice Insight’s CRO Leadership Award for Excellence in Regulatory and Productivity, and winner of Best Places to Work in the Triangle by the Triangle Business Journal.
For more information, visit https://careers-rhoworld.icims.com/.
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 33 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience.